LaVoie Group, the trusted leader in life science and pharmaceutical communications, was recognized by Inc. Magazine as number 2,375 on the fifth annual list of the 5,000 fastest growing private companies in the United States. In the advertising and marketing category, LaVoie Group was listed as number 227 and in Boston as number 74.The agency also announced its 2010 ranking as number 29 in the U.S. on O'Dwyer's list of independent healthcare public relations firms, and number 11 in Massachusetts. This compares with LaVoie Group's prior ranking in the top 40 nationally."The ability to work with leading brands and innovators in healthcare provides an incredible opportunity for LaVoie Group," said Donna LaVoie, President & CEO. "We are laser focused on delivering high value corporate and marketing communications, public and investor relations counsel and execution. Navigating in a shifting environment where new channels in social networking have become more pronounced has been the key to our success. Messaging and positioning is paramount to our service offering today and the team is proud to be recognized for its accomplishments.""Now, more than ever, we depend on Inc. 500/5000 companies to spur innovation, provide jobs, and drive the economy forward. Growth companies, not large corporations, are where the action is," said Inc. Magazine's Editor, Jane Berentson.In a stagnant economic environment, the median growth rate of the 2011 Inc. 500/5000 companies reached an impressive 94%. The companies on this year's list report having created 350,000 jobs in the past three years. Aggregate revenue among the honorees reached $366 billion, up 14% from last year.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment